foxo4 dri peptide senolytic 2023 2024 study

foxo4 dri peptide senolytic 2023 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer

Name: foxo4 dri peptide senolytic 2023 2024 study inhibitors targeting FOXO4-p53 interactions and inducing senescent cancer cell-specific apoptosis FOXO4-DRI: Human Trial Status, Cancer
Brand: webdevsolutions.tech
SKU: 15251014620
Price: 24.49 USD
Availability: InStock
Rating: 4.6138 (28 reviews)

FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data FOXO4 DRI improves spermatogenesis in aged mice through reducing senescence associated secretory phenotype secretion from Leydig cells ScienceDirect ES2 rapidly destroys TP53 FOXO4 foci leading to TP53 mediated Download Scientific Diagram foxo4 dri peptide senolytic mouse study 2023 2024 Molecular modelling of the FOXO4 TP53 interaction to design peptides for the elimination of senescent cancer cells FOXO4 DRI Peptide for Cellular

SKU: 15251014620 · From webdevsolutions.tech

4.6

USD24.49 USD67.49

Pay in 4 interest-free payments of $6.12 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 18 - Aug 23

Description

DOI: 10.1007/s00018-005-4560-2

These are standard precautions and regulatory review will determine the full contraindication and warning profile ahead of any potential market authorisation